Infinity Pharmaceuticals Stock Z Score
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Infinity |
Infinity Pharmaceuticals Company Z Score Analysis
Infinity Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Infinity Pharmaceuticals Z Score | -29.4 |
Most of Infinity Pharmaceuticals' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Infinity Pharmaceuticals has a Z Score of -29.4. This is 535.56% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.
Infinity Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infinity Pharmaceuticals' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infinity Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuticals by comparing valuation metrics of similar companies.Infinity Pharmaceuticals is currently under evaluation in z score category among its peers.
Infinity Fundamentals
Return On Equity | -35.21 | |||
Return On Asset | -0.61 | |||
Operating Margin | (15.70) % | |||
Current Valuation | (9.46 M) | |||
Shares Outstanding | 90.76 M | |||
Shares Owned By Insiders | 2.36 % | |||
Shares Owned By Institutions | 23.48 % | |||
Number Of Shares Shorted | 2.21 M | |||
Price To Earning | (1.63) X | |||
Price To Book | 8.03 X | |||
Price To Sales | 19.29 X | |||
Revenue | 2.59 M | |||
Gross Profit | (31.38 M) | |||
EBITDA | (44.84 M) | |||
Net Income | (44.37 M) | |||
Cash And Equivalents | 56.58 M | |||
Cash Per Share | 0.63 X | |||
Total Debt | 917 K | |||
Debt To Equity | 0.13 % | |||
Current Ratio | 4.16 X | |||
Book Value Per Share | (0.41) X | |||
Cash Flow From Operations | (42.43 M) | |||
Short Ratio | 0.31 X | |||
Earnings Per Share | (0.45) X | |||
Price To Earnings To Growth | (0.05) X | |||
Target Price | 0.3 | |||
Number Of Employees | 30 | |||
Beta | 1.38 | |||
Market Capitalization | 2.63 M | |||
Total Asset | 42.15 M | |||
Retained Earnings | (855.95 M) | |||
Working Capital | 26.67 M | |||
Current Asset | 254.7 M | |||
Current Liabilities | 70.06 M | |||
Z Score | -29.4 | |||
Net Asset | 42.15 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Infinity Stock
If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |